In mouse models of PD, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment results in higher levels of CDK5 and its specific activator, the P25 complex, in dopaminergic neurons, leading to neuronal death [22]. Here, CDK5 is linked to Parkinson disease.